+

WO1999002659A3 - Method of altering the domains of cyclosporin synthetase to give a modified cyclosporin synthetase - Google Patents

Method of altering the domains of cyclosporin synthetase to give a modified cyclosporin synthetase Download PDF

Info

Publication number
WO1999002659A3
WO1999002659A3 PCT/EP1998/004265 EP9804265W WO9902659A3 WO 1999002659 A3 WO1999002659 A3 WO 1999002659A3 EP 9804265 W EP9804265 W EP 9804265W WO 9902659 A3 WO9902659 A3 WO 9902659A3
Authority
WO
WIPO (PCT)
Prior art keywords
cyclosporin
synthetase
cyclosporin synthetase
modified
altering
Prior art date
Application number
PCT/EP1998/004265
Other languages
French (fr)
Other versions
WO1999002659A2 (en
Inventor
Kurt Schoergendorfer
Guenther Stempfer
Holger Husi
Malcolm Douglas Walkinshaw
Original Assignee
Biochemie Gmbh
Kurt Schoergendorfer
Guenther Stempfer
Holger Husi
Malcolm Douglas Walkinshaw
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochemie Gmbh, Kurt Schoergendorfer, Guenther Stempfer, Holger Husi, Malcolm Douglas Walkinshaw filed Critical Biochemie Gmbh
Priority to AU86311/98A priority Critical patent/AU8631198A/en
Priority to EP98937563A priority patent/EP0994943A2/en
Publication of WO1999002659A2 publication Critical patent/WO1999002659A2/en
Publication of WO1999002659A3 publication Critical patent/WO1999002659A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93Ligases (6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The method of altering the domains of cyclosporin synthetase, to modified cyclosproin synthetase, to methods for the production of cyclosporin-like peptides or derivatives using the modified cyclosporin synthetase and to the cyclosporin-like peptides or derivatives.
PCT/EP1998/004265 1997-07-09 1998-07-09 Method of altering the domains of cyclosporin synthetase to give a modified cyclosporin synthetase WO1999002659A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU86311/98A AU8631198A (en) 1997-07-09 1998-07-09 Method of altering the domains of cyclosporin synthetase to give a modified cyclosporin synthetase
EP98937563A EP0994943A2 (en) 1997-07-09 1998-07-09 Method of altering the domains of cyclosporin synthetase to give a modified cyclosporin synthetase

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9714475.2A GB9714475D0 (en) 1997-07-09 1997-07-09 Organic compounds
GB9714475.2 1997-07-09

Publications (2)

Publication Number Publication Date
WO1999002659A2 WO1999002659A2 (en) 1999-01-21
WO1999002659A3 true WO1999002659A3 (en) 1999-05-14

Family

ID=10815609

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1998/004265 WO1999002659A2 (en) 1997-07-09 1998-07-09 Method of altering the domains of cyclosporin synthetase to give a modified cyclosporin synthetase

Country Status (4)

Country Link
EP (1) EP0994943A2 (en)
AU (1) AU8631198A (en)
GB (1) GB9714475D0 (en)
WO (1) WO1999002659A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7378391B2 (en) 2004-09-29 2008-05-27 Amr Technology, Inc. Cyclosporin alkyne analogues and their pharmaceutical uses
US7511013B2 (en) 2004-09-29 2009-03-31 Amr Technology, Inc. Cyclosporin analogues and their pharmaceutical uses
US7538084B2 (en) 2003-03-17 2009-05-26 Amr Technology, Inc. Cyclosporins
US7632807B2 (en) 2004-10-06 2009-12-15 Albany Molecular Research, Inc. Cyclosporin alkynes and their utility as pharmaceutical agents

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19928313A1 (en) * 1999-06-16 2000-12-21 Ullrich Keller Processes for altering peptide synthesis so that they can N-methylate their substrate amino acids
US6603902B1 (en) 1999-10-26 2003-08-05 Bti Photonics Inc. Wavelength selective variable reflector

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0578616A2 (en) * 1992-07-09 1994-01-12 Sandoz Ltd. Cylosporin synthetase

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0578616A2 (en) * 1992-07-09 1994-01-12 Sandoz Ltd. Cylosporin synthetase

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
A. LAWEN AND R. TRABER: "Substrates specificities of cyclosporin synthetase and peptolide SDZ 214-103 synthetase", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 268, no. 27, 1993, pages 20452 - 20465, XP002094831 *
G. WEBER ET AL.,: "The peptide synthetase catalyzing cyclosporine production in Tolypocladium niveum is encoded by a giant 45.8-kilobase open reading frame", CURRENT GENETICS, vol. 26, no. 2, 1994, pages 120 - 125, XP002094832 *
H. HUSI ET AL.,: "Prediction of substrate-specific pockets in cyclosporin synthetase", FEBS LETTERS, vol. 414, no. 3, - 15 September 1997 (1997-09-15), pages 532 - 536, XP002094835 *
J. DITTMANN ET AL.,: "Mechanism of cyclosporin A biosynthesis", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 269, no. 4, 1994, pages 2841 - 2846, XP002094833 *
T. STACHELHAUS AND M.A. MARAHIEL: "Modular structure of genes encoding multifunctional peptide synthetases required for non-ribosomal peptide synthesis", FEMS MICROBIOLOGY LETTERS, vol. 125, no. 1, 1995, pages 3 - 14, XP002094834 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7538084B2 (en) 2003-03-17 2009-05-26 Amr Technology, Inc. Cyclosporins
US7378391B2 (en) 2004-09-29 2008-05-27 Amr Technology, Inc. Cyclosporin alkyne analogues and their pharmaceutical uses
US7511013B2 (en) 2004-09-29 2009-03-31 Amr Technology, Inc. Cyclosporin analogues and their pharmaceutical uses
US7632807B2 (en) 2004-10-06 2009-12-15 Albany Molecular Research, Inc. Cyclosporin alkynes and their utility as pharmaceutical agents

Also Published As

Publication number Publication date
EP0994943A2 (en) 2000-04-26
WO1999002659A2 (en) 1999-01-21
GB9714475D0 (en) 1997-09-17
AU8631198A (en) 1999-02-08

Similar Documents

Publication Publication Date Title
AU7489596A (en) Reinforced formed part, process for its production and its use
AU5194999A (en) Benzothiepin derivatives, process for the preparation of the same and uses thereof
WO2001079461A3 (en) Polypeptides having haloperoxidase activity
ZA987540B (en) Process for the preparation of stanol esters, and use thereof.
AU6136499A (en) Injector, methods for using injector, and kit
AU6059699A (en) Synthetic peptides, conjugation reagents and methods
AU8562898A (en) Thienopyridine derivatives, intermediates thereof, and process for producing theboth
WO2001014566A3 (en) Enzymatic synthesis of deoxyribonucleosides
AU3425700A (en) Non-ribosomal peptide synthetases, method for producing same and the use thereof
AU2046297A (en) Method for the manufacture of ammonia
AU7938294A (en) Method for controlled modification of enzymes, enzymes modified in this way and the use of such enzymes
WO2000022019A3 (en) Coupled block copolymers and process for producing the block copolymers
WO1999002659A3 (en) Method of altering the domains of cyclosporin synthetase to give a modified cyclosporin synthetase
AU3732400A (en) Clockworks, timepiece and method for operating the same
AU1534999A (en) Weather-resistant mineral and protein supplement feeds, and methods of making same
AU5696796A (en) Recombinant preduodenal lipases and polypeptides derivatives produced by plants, processes for obtaining them and their uses
IT1290923B1 (en) BAG AND METHOD FOR THE PRODUCTION OF THE SAME.
AU7676698A (en) Method for the production of a branched macromolecule, the branched macromolecule and uses thereof
WO1999010480A3 (en) New tissue-specific calpaines, their production and their use
AU5545896A (en) H. Influenzae HxuB and HxuC genes, proteins and methods of use
AU9245498A (en) Substantially inorganic matter, froth product obtained therefrom and method for the production of said matter
AU2002213954A1 (en) Method for the selective modification of peptides and proteins
AU7478098A (en) Methods of treatment using nbs-1, antibodies and proteins thereto, and uses of the antibodies
AU2742397A (en) Processes for producing 1,6-hexanedials and derivatives
AU6123396A (en) Imidazo{1,5a}pyridine derived serine protease inhibitors

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 1998937563

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: KR

WWP Wipo information: published in national office

Ref document number: 1998937563

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1998937563

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载